All articles published by MDPI are made immediately available worldwide under an open access license. No special
permission is required to reuse all or part of the article published by MDPI, including figures and tables. For
articles published under an open access Creative Common CC BY license, any part of the article may be reused without
permission provided that the original article is clearly cited. For more information, please refer to
https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature
Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for
future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive
positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
Editors select a small number of articles recently published in the journal that they believe will be particularly
interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the
most exciting work published in the various research areas of the journal.
The “Cancer and Cancer-Related Diseases” section of the open-access journal Medical Sciences provides a forum for the publication of studies investigating basic, translational, and clinical aspects of this diverse group of diseases. This section publishes comprehensive reviews, as well as scientifically sound original research reports that advance insight into relevant subject areas, ranging from the understanding of fundamental molecular mechanisms of carcinogenesis to clinical trial therapies and outcomes.
Original reviews and research articles related to, but not limited to, the following are invited:
Cancer genetics and epigenetics;
Cancer immunity and immunotherapy;
Tumor microenvironment;
Cancer prevention;
Cancer treatment, management, and resistance;
Cancer epidemiology;
Diagnostic and prognostic indicators, including cancer biomarkers and precision medicine;